Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 84 NIH 31 INDUSTRY 30 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1

Interventions

Specimen Handling 46 Magnetic Resonance Spectroscopy 37 Cyclophosphamide 28 Vincristine 20 Radiation 19 Dexamethasone 19 Cisplatin 18 Biopsy 18 Radiotherapy 17 Etoposide 17 Carboplatin 16 Cytarabine 13 Leucovorin 12 daratumumab 11 Methotrexate 11 durvalumab 10 Standard of Care 10 Radiotherapy, Intensity-Modulated 10 Platinum 10 Gemcitabine 10 Doxorubicin 10 Docetaxel 10 Practice Guidelines as Topic 9 Calcium Dobesilate 9 1,2-diaminocyclohexaneplatinum II citrate 9 merphos 8 dexamethasone acetate 8 dexamethasone 21-phosphate 8 auricularum 8 X-Rays 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Ipilimumab × 90 days × Clear all

NCT03297606 2026-03-27

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡